SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-19-007052
Filing Date
2019-05-14
Accepted
2019-05-14 15:20:01
Documents
5
Effectiveness Date
2019-05-14

Document Format Files

Seq Description Document Type Size
1 defa14a.htm DEFA14A 33440
2 notice_001.jpg GRAPHIC 92619
3 notice_002.jpg GRAPHIC 120608
4 notice_003.jpg GRAPHIC 51483
5 notice_004.jpg GRAPHIC 45208
  Complete submission text file 0001493152-19-007052.txt   461961
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36457 | Film No.: 19822385
SIC: 2834 Pharmaceutical Preparations